Lexaria Bioscience (LEXX) FCF Margin (2017 - 2026)
Lexaria Bioscience (LEXX) recorded FCF Margin of -11023.44% in fiscal Q2 2026 (quarter ended Feb 28, 2026), down 10162.58 percentage points from -860.86% a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) FCF Margin (2017 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience reported FCF Margin of -1483.88%, down 406.50 percentage points from FY2024.
- Annual FCF Margin has a five-year change of -651.97 percentage points (FY2020 to FY2025).
- Across earlier fiscal years, FCF Margin came in at -1077.38% in FY2024 (+1537.47 pp), -2614.84% in FY2023 (-685.09 pp), -1929.75% in FY2022 (-1377.73 pp) and -552.02% in FY2021 (+279.88 pp).
- The fiscal Q2 2026 figure is the lowest quarterly FCF Margin in data going back to fiscal Q1 2018.
- On a year-over-year basis, FCF Margin rose in three of the last seven quarters, with an average year-over-year change of -1045.05 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 7413.06 percentage points in fiscal Q1 2023, against a drop of 10162.58 percentage points in fiscal Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Lexaria Bioscience | 3.39 Mn | -12.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | -11,023.44% |
| Aug 31, 2025 | -1,518.68% |
| May 31, 2025 | -2,059.74% |
| Feb 28, 2025 | -860.86% |
| Nov 30, 2024 | -1,495.57% |
| Aug 31, 2024 | -2,303.18% |
| May 31, 2024 | -1,507.23% |
| Feb 29, 2024 | -427.32% |
| Nov 30, 2023 | -781.11% |
| Aug 31, 2023 | -5,275.30% |
| May 31, 2023 | -2,298.33% |
| Feb 28, 2023 | -6,199.88% |
| Nov 30, 2022 | -1,295.15% |
| Aug 31, 2022 | -1,058.59% |
| May 31, 2022 | -1,269.54% |
| Feb 28, 2022 | -4,167.28% |
| Nov 30, 2021 | -8,708.21% |
| Aug 31, 2021 | -3,585.28% |
| May 31, 2021 | -566.86% |
| Feb 28, 2021 | -332.22% |
API Access
Lexaria Bioscience FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();